Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.37 |
| ▸ | ARG1 | P05089 | 1/20 | 0.36 |
| ▸ | ARG2 | P78540 | 1/20 | 0.36 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14075760 | 1.00 | CYP1A2 (0.56) | CYP1A2CYP2C9HPGDMAPK1HIF1A | |
| SCHEMBL7847332 | 0.97 | CYP1A2 (0.58) | CYP1A2CYP2C9HPGDMAPK1HIF1A | |
| SCHEMBL7847871 | 0.97 | CYP1A2 (0.58) | CYP1A2CYP2C9HPGDMAPK1HIF1A | |
| SCHEMBL3923168 | 0.97 | CYP1A2 (0.58) | CYP1A2CYP2C9HPGDMAPK1HIF1A | |
| SCHEMBL2845423 | 0.94 | CYP1A2 (0.50) | CYP1A2CYP2C9HPGDMAPK1HIF1A | |
| SCHEMBL21531945 | 0.94 | CYP1A2 (0.56) | CYP1A2CYP2C9HPGDMAPK1HIF1A | |
| Diethylaminoethanol SCHEMBL10699915 | 0.94 | — | — | |
| Diethylaminoethanol SCHEMBL3114 | 0.94 | — | — | |
| SCHEMBL35602 | 0.94 | — | — | |
| Diethylaminoethanol SCHEMBL20815437 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4504665-A1 | ELECTROCHEMICAL OXIDATION OF AMINE COMPLEXANTS IN WASTE STREAMS FROM ELECTROPLATING PROCESSES | MacDermid, Incorporated (US) | 2025-02-12 | — | — | EP | claimed |
| US-20230322588-A1 | Electrochemical Oxidation of Amine Complexants in Waste Streams from Electroplating Processes | MACDERMID, INCORPORATED | 2023-10-12 | — | — | US | claimed |
| WO-2023196226-A1 | ELECTROCHEMICAL OXIDATION OF AMINE COMPLEXANTS IN WASTE STREAMS FROM ELECTROPLATING PROCESSES | MACDERMID, INCORPORATED (US) | 2023-10-12 | — | — | WO | claimed |
| EP-2878609-B1 | AMINE CATALYST FOR CURING POLYISOCYANATE COMPOUND AND POLYISOCYANATE ADHESIVE COMPOSITION CONTAINING AMINE CATALYST FOR CURING POLYISOCYANATE COMPOUND | TOSOH CORP (JP) | 2019-06-05 | — | — | EP | claimed |
| US-9777199-B2 | Amine catalyst for curing polyisocyanate compound and polyisocyanate adhesive composition containing amine catalyst for curing polyisocyanate compound | TOSOH CORPORATION (JP) | 2017-10-03 | — | — | US | claimed |
| US-20150203727-A1 | AMINE CATALYST FOR CURING POLYISOCYANATE COMPOUND AND POLYISOCYANATE ADHESIVE COMPOSITION CONTAINING AMINE CATALYST FOR CURING POLYISOCYANATE COMPOUND | TOSOH CORPORATION (JP) | 2015-07-23 | — | — | US | claimed |
| EP-2878609-A1 | AMINE CATALYST FOR CURING POLYISOCYANATE COMPOUND AND POLYISOCYANATE ADHESIVE COMPOSITION CONTAINING AMINE CATALYST FOR CURING POLYISOCYANATE COMPOUND | Tosoh Corporation (JP) | 2015-06-03 | — | — | EP | claimed |
| US-20260102348-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | FUJIFILM CORPORATION (JP) | 2026-04-16 | — | — | US | disclosed |
| EP-4332086-B1 | COMPOUND OR SALT THEREOF, LIPID PARTICLES, AND PHARMACEUTICAL COMPOSITION | FUJIFILM CORP (JP) | 2026-04-08 | — | — | EP | disclosed |
| US-12546027-B2 | Anode for electroplating, and method and system for electroplating articles with metal | DIPSOL CHEMICALS CO., LTD. (JP) | 2026-02-10 | — | — | US | disclosed |
| US-12508226-B2 | Lipid composition | FUJIFILM CORPORATION (JP) | 2025-12-30 | — | — | US | disclosed |
| EP-4644589-A2 | ALKALINE ZINC-NICKEL ALLOY PLATING SOLUTION AND ZINC-NICKEL ALLOY BARREL PLATING METHOD USING THE SAME | Dipsol Chemicals Co., Ltd. (JP) | 2025-11-05 | — | — | EP | disclosed |
| US-12370143-B2 | Compound or salt thereof and lipid particles | FUJIFILM CORPORATION (JP) | 2025-07-29 | — | — | US | disclosed |
| US-20050189231-A1 | Articles with electroplated zinc-nickel ternary and higher alloys, electroplating baths, processes and systems for electroplating such alloys | ATOTECH USA, LLC | 2005-09-01 | — | — | US | disclosed |
| US-20050133376-A1 | Alkaline zinc-nickel alloy plating compositions, processes and articles therefrom | ATOTECH USA, LLC | 2005-06-23 | — | — | US | disclosed |
| US-6436269-B1 | COMPRISING SOLUBLE METAL COMPOUNDS AND A CATIONIC POLYMER USED FOR ELECTRODEPOSITION OF METALS HAVING BRIGHT, UNIFORM COATINGS AND A WIDE CURRENT DENSITY RANGE; SOLDERS | ATOTECH DEUTSCHLAND GMBH (DE) | 2002-08-20 | — | — | US | disclosed |
| EP-1201789-A2 | Plating bath and method for electroplating tin-zinc alloys | ATOTECH Deutschland GmbH (DE) | 2002-05-02 | — | — | EP | disclosed |
| EP-0649918-B1 | Alkaline zinc-nickel alloy plating baths | ROHCO INC MCGEAN (US) | 1996-11-20 | — | — | EP | disclosed |
| US-5417840-A | Quaternary ammonium compound containing nitrogen heterocycle, brightness | MCGEAN-ROHCO, INC. (US) | 1995-05-23 | — | — | US | disclosed |
| EP-0649918-A1 | Alkaline zinc-nickel alloy plating baths | MCGEAN-ROHCO, INC. (US) | 1995-04-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12370143-B2 | Compound or salt thereof and lipid particles | NR1H3, NR1H2, LDLR | CYP1A2 1806/4885CYP2C9 1329/4885HPGD 4024/4885 |
| US-20260102348-A1 | COMPOUND OR SALT THEREOF AND LIPID PARTICLES | LDLR, NR1H3, NR1H2 | CYP1A2 3645/4885CYP2C9 3691/4885HPGD 3851/4885 |
| US-12508226-B2 | Lipid composition | APOB, NAF1, SLC27A1 | CYP1A2 4015/4885CYP2C9 3085/4885HPGD 4328/4885 |
| US-12546027-B2 | Anode for electroplating, and method and system for electroplating articles with metal | DCX, CACNA2D3, CACNA2D4 | CYP1A2 2034/4885CYP2C9 4023/4885HPGD 4063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.